European Market Report for Nebulizers 2016 – MedCore

European Market Report for Nebulizers 2016 – MedCore

0

The nebulizer market is composed of stationary and portable jet compressor nebulizers, as well as vibrating mesh and ultrasonic nebulizers. The goal of nebulizers is to produce an aerosol form of drug delivery so that the compound can be delivered as a fine mist and be readily metabolized. Many different drugs must be delivered as a fine mist, thus the severity, or need for these devices depends on the prevalence of the diseases that require them. Jet compressor nebulizers are the oldest, and least effective aerosolizers of the nebulizers currently available, however they are still effective, and significantly more cost-effective than the vibrating mesh and ultrasonic nebulizers.

  • Year: 2016
  • Scope: 2012-2022
  • Region: Europe
  • Published Date: 08/01/2016
  • Pages: 83
  • Type: MedCore

Inhalation drug therapies are an integral component of treatment for a wide variety of diseases, including cystic fibrosis, asthma and chronic obstructive pulmonary disease (COPD). COPD in particular has become increasingly prevalent in recent years, and pulmonary inhalation therapies have been identified as a cornerstone in treatment and symptom relief. Additionally, the use of inhalation drugs has been applied to many specialties of medicine leading to inhalation treatments for diabetes, migraine, and even advanced cancer therapies. For these types of medication to be effective, particle size is an all-important factor in ensuring maximum absorption of the drug into the soft tissue of the lungs. The smaller the particles the inhaled medication can be broken down into, the better the dispersal in the air breathed in and the greater percentage of medication reaches the alveoli of the lungs, where the exchange with the circulatory system takes place.
There are three primary drug delivery technologies used in the European markets: dry powder inhalants (DPIs), metered dose inhalers (MDIs) and nebulizers. MDIs, sometimes referred to colloquially as “puffers,” are the most common type of inhaler. In MDIs, the drug is generally stored in a pressurized canister than contains the medication along with a propellant. The canister is attached to a hand-operated actuator which, when activated by the patient, releases a set dose of medication in an aerosol form. DPIs release a dose of medicine as a powder aerosol that is inhaled by the patient, but their use has been limited due to the market dominance of MDIs. Nebulizers provide continuous aerosol spray with the aid of an external energy source.



The "European Market Report Suite for Anesthesia, Respiratory and Sleep Management Devices 2016 - MedSuite" includes analysis on the following companies currently active in this market:
Philips Respironics
ResMed
GE Healthcare
Dräger
Medtronic - Covidien
Teleflex Medical
Fisher & Paykel
Invacare
Smiths Medical
Ambu - King
Carefusion - BD
Intersurgical
Maquet
Flexicare
PARI
Breas
DeVilbiss - Drive
Mindray
AirSep
SOMNOmedics
Others include: Aerogen, Aire Liquide, Alpha Trace, Apax - AirLife, BESCO, beurer, BMC, Ca-Mi, CONTEC, Degmed, digiO2, elmaslar, EVO Medical, Giotto, Grass Technologies, Hans Rudolph, HCMedi, Heyer, Hoffrichter Gmbh, Inogen, Kare, Lanaform, Legend, Marshall, MEDATEC, Metaltronica, MGC Diagnostics, NCC, Neurosoft, Norditalia, Nouvag, NOVAPLUS, Planmed, RanaCareGroup, Salter Labs, Schill, SeQual, Shinmed, SIARE, SLE Ltd, Spacelabs, Stephan GmbH, TaiDoc, Weinmann, VitalAire
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link